Statistics

TCRex currently provides prediction models for 48 different epitopes including 43 viral and 5 cancer epitopes. Performance metrics of these prediction models for the latest model version (i.e. version 2026-03-30) are shown in the tables below.

Cancer Epitope Version Nr. of sequences Balanced accuracy AUROC Average precision
Melanoma AMFWSVPTV 2026-03-30 82 0.57 ± 0.05 0.79 ± 0.05 0.46 ± 0.1
Melanoma EAAGIGILTV 2026-03-30 266 0.69 ± 0.03 0.9 ± 0.01 0.73 ± 0.03
Melanoma ELAGIGILTV 2026-03-30 1035 0.54 ± 0.01 0.71 ± 0.01 0.38 ± 0.02
Melanoma FLYNLLTRV 2026-03-30 61 0.64 ± 0.06 0.84 ± 0.04 0.55 ± 0.12
Multiple Myeloma LLLGIGILV 2026-03-30 233 0.57 ± 0.01 0.76 ± 0.03 0.41 ± 0.03
Viral Epitope Version Nr. of sequences Balanced accuracy AUROC Average precision
HCV ARMILMTHF 2026-03-30 66 0.74 ± 0.06 0.87 ± 0.06 0.69 ± 0.11
HCV ATDALMTGY 2026-03-30 177 0.74 ± 0.03 0.91 ± 0.03 0.76 ± 0.06
HCV CINGVCWTV 2026-03-30 131 0.53 ± 0.03 0.77 ± 0.07 0.39 ± 0.13
HIV EIYKRWII 2026-03-30 185 0.66 ± 0.03 0.75 ± 0.04 0.52 ± 0.05
EBV EPLPQGQLTAY 2026-03-30 36 0.63 ± 0.08 0.91 ± 0.06 0.75 ± 0.15
HIV FLKEKGGL 2026-03-30 156 0.61 ± 0.03 0.75 ± 0.05 0.47 ± 0.09
HIV FPRPWLHGL 2026-03-30 120 0.8 ± 0.03 0.94 ± 0.01 0.85 ± 0.03
HIV FRDYVDRFYKTLRAEQASQE 2026-03-30 367 0.87 ± 0.02 1.0 ± 0.0 0.97 ± 0.0
Influenza GILGFVFTL 2026-03-30 3107 0.68 ± 0.01 0.82 ± 0.02 0.6 ± 0.03
EBV GLCTLVAML 2026-03-30 1208 0.66 ± 0.01 0.81 ± 0.01 0.58 ± 0.01
DENV2 GTSGSPIIDK 2026-03-30 60 0.61 ± 0.06 0.83 ± 0.06 0.56 ± 0.06
DENV3/4 GTSGSPIINR 2026-03-30 158 0.71 ± 0.02 0.86 ± 0.03 0.71 ± 0.02
DENV1 GTSGSPIVNR 2026-03-30 165 0.77 ± 0.06 0.89 ± 0.04 0.77 ± 0.06
HIV HPKVSSEVHI 2026-03-30 75 0.71 ± 0.08 0.83 ± 0.09 0.71 ± 0.14
EBV HPVGEADYFEY 2026-03-30 32 0.73 ± 0.1 0.87 ± 0.09 0.62 ± 0.2
HCV HSKKKCDEL 2026-03-30 45 0.8 ± 0.06 0.97 ± 0.01 0.85 ± 0.07
HIV IIKDYGKQM 2026-03-30 54 0.81 ± 0.09 0.94 ± 0.03 0.83 ± 0.06
CMV IPSINVHHY 2026-03-30 85 0.7 ± 0.02 0.83 ± 0.06 0.67 ± 0.06
HIV ISPRTLNAW 2026-03-30 58 0.61 ± 0.06 0.8 ± 0.04 0.56 ± 0.11
EBV IVTDFSVIK 2026-03-30 46 0.64 ± 0.03 0.82 ± 0.05 0.55 ± 0.06
HIV KAFSPEVIPMF 2026-03-30 210 0.74 ± 0.02 0.88 ± 0.03 0.7 ± 0.04
HCV KLVALGINAV 2026-03-30 65 0.6 ± 0.04 0.75 ± 0.06 0.49 ± 0.08
HIV KRWIILGLNK 2026-03-30 396 0.66 ± 0.03 0.85 ± 0.05 0.67 ± 0.08
HIV KRWIIMGLNK 2026-03-30 75 0.71 ± 0.03 0.85 ± 0.1 0.72 ± 0.11
YellowFeverVirus LLWNGPMAV 2026-03-30 474 0.66 ± 0.01 0.79 ± 0.01 0.54 ± 0.02
HIV LPPIVAKEI 2026-03-30 62 0.78 ± 0.04 0.89 ± 0.06 0.76 ± 0.1
Influenza LPRRSGAAGA 2026-03-30 2137 0.54 ± 0.0 0.84 ± 0.01 0.39 ± 0.02
CMV NLVPMVATV 2026-03-30 4812 0.56 ± 0.0 0.73 ± 0.01 0.39 ± 0.01
HIV QVPLRPMTYK 2026-03-30 48 0.65 ± 0.04 0.8 ± 0.1 0.53 ± 0.17
CMV QYDPVAALF 2026-03-30 41 0.69 ± 0.07 0.87 ± 0.06 0.67 ± 0.07
EBV RAKFKQLL 2026-03-30 262 0.65 ± 0.02 0.9 ± 0.01 0.7 ± 0.03
HIV RFYKTLRAEQASQ 2026-03-30 210 0.9 ± 0.03 0.99 ± 0.0 0.96 ± 0.01
HIV RLRPGGKKK 2026-03-30 31 0.68 ± 0.06 0.86 ± 0.12 0.64 ± 0.19
HSV2 RPRGEVRFL 2026-03-30 63 0.78 ± 0.05 0.93 ± 0.04 0.83 ± 0.08
HIV RYPLTFGWCF 2026-03-30 30 0.52 ± 0.03 0.78 ± 0.11 0.45 ± 0.12
HTLV1 SFHSLHLLF 2026-03-30 131 0.67 ± 0.03 0.79 ± 0.06 0.58 ± 0.07
HIV TPGPGVRYPL 2026-03-30 86 0.69 ± 0.03 0.88 ± 0.03 0.74 ± 0.05
HIV TPQDLNTML 2026-03-30 159 0.82 ± 0.02 0.94 ± 0.04 0.86 ± 0.05
CMV TPRVTGGGAM 2026-03-30 258 0.72 ± 0.01 0.89 ± 0.03 0.75 ± 0.03
CMV VTEHDTLLY 2026-03-30 277 0.55 ± 0.0 0.8 ± 0.02 0.43 ± 0.03
SARS-CoV-2 YLQPRTFLL 2026-03-30 315 0.91 ± 0.01 0.97 ± 0.01 0.91 ± 0.01
CMV YSEHPTFTSQY 2026-03-30 74 0.59 ± 0.05 0.92 ± 0.04 0.77 ± 0.08
EBV YVLDHLIVV 2026-03-30 103 0.54 ± 0.02 0.79 ± 0.04 0.48 ± 0.07